Company: IXHL
Filing Date: 2025-05-20
Form Type: 8-K
Source: 0001213900-25-045641
Chunk: 0

Company: Incannex Healthcare Inc.
Filing Date: 2025-05-20
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events.

On May 20, 2025, Incannex Healthcare Inc. (the
“ Company”) filed a prospectus supplement to increase the maximum number of shares (the “ Shares”) of the Company’s
common stock, par value $0.0001 per share, issuable pursuant to the Sales Agreement between the Company and A. G. P/Alliance Global Partners,
dated as of April 7, 2025 (the “ Sales Agreement”), to up to an aggregate of $2,514,214 of Shares, which does not include the Shares
having an aggregate gross sales price of approximately $16,768,095 that have been sold to date under the Sales Agreement.

Attached hereto as Exhibit 5.1 to this Current
Report is the opinion of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P. C., relating to the legality of the issuance and sale of the
Shares.

Item 9.01 Financial Statements and Exhibits.